MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$44,740K
Depreciation and
amortization
$27,385K
Change in inventories
-$13,841K
Change in accounts
receivable
-$11,058K
Proceeds from employee
stock purchase plan
$2,623K
Share-based compensation
expense
$7,799K
Other non-cash
operating activities
$2,072K
Amortization of fair value
inventory step-up
$1,323K
Impairment of intangible
assets
$716K
Proceeds from exercise of
stock options
$1,147K
Net cash provided by
operating activities
$93,564K
Net cash (used in)
provided by financing...
$2,033K
Effect of exchange
rates on cash and cash...
$810K
Canceled cashflow
$15,370K
Canceled cashflow
$1,737K
Net change in cash
and cash...
$66,941K
Canceled cashflow
$29,466K
Change in accounts
payable and accrued...
-$6,696K
Change in other assets
and other...
$4,610K
Deferred income taxes
-$2,062K
Change in prepaid
income taxes
$1,784K
Gains on sales of
property, plant and...
$218K
Proceeds from sale of
property, plant and...
$432K
Repayment of term loan
borrowings
$1,563K
Cash used to net share
settle employee equity...
$160K
Other financing
activities
-$14K
Net cash used in
investing activities
-$29,466K
Canceled cashflow
$432K
Non-cash transfers from
inventory to property,...
-$13,444K
Other investments
$10,105K
Capital expenditures
$6,349K
Back
Back
Cash Flow
source: myfinsight.com
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)